Sorrento Therapeutics - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

CVS stock slips as Aetna settles Medicare Advantage diagnosis code fraud case for $117.7m

What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)

CVGI surges 54% as CVG names Zoox strategic supplier and issues $700M revenue outlook for 2026

Representative image illustrating rising takeover speculation around Papa John’s International, Inc., as renewed private equity interest and a reported $65-per-share bid from TriArtisan Capital Advisors push the PZZA stock back into focus amid ongoing turnaround efforts.

Papa John’s agrees to explore sale as renewed private equity interest lifts PZZA

Read More

1 minute read

Healthcare Industry News

Sorrento Therapeutics acquires majority stake in Zhengzhou FortuneBio

Sorrento Therapeutics has acquired a majority stake in Zhengzhou Fortune Bioscience (Zhengzhou FortuneBio), a Chinese diagnostic manufacturer, for…

byPallavi Madhiraju

February 20, 2022

Read More

2 minute read

Pharma Industry News

Sorrento Therapeutics says STI-1499 fully inhibited SARS-CoV-2 virus

Sorrento Therapeutics said that STI-1499, its anti-SARS-CoV-2 antibody, showed 100% inhibition of SARS-CoV-2 virus infection in an in…

bypharmanewsdaily

May 15, 2020

Read More

1 minute read

Pharma Industry News

Sorrento Therapeutics turns down $993m takeover bid from private equity firm

Sorrento Therapeutics, a California-based biopharma company, has turned down a takeover bid worth about $993 million from an…

bypharmanewsdaily

January 27, 2020

web analytics